252
Participants
Start Date
September 30, 2000
Primary Completion Date
September 30, 2004
Study Completion Date
December 31, 2006
Bupropion
Smoking Abstinence Program
This investigation was a randomized controlled study of two framed message conditions for smoking cessation in combination with open label bupropion SR (300 mg/day). Two hundred fifty-eight cigarette smokers were randomly assigned to receive either gain- or loss-framed video and printed messages encouraging smoking abstinence. Preproduced video and printed information were chosen as the intervention media because of their reliability in delivering specific framed messages. All participants were seen at a community mental health center for 6 months and received a 7-week supply of bupropion SR.
Substance Abuse Treatment Unit, New Haven
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER